After one year of treatment, those on dialysis have a 15-20% mortality rate,
So if those currently on dialysis continue at the same mortality rate BUT you slow the rate of new patients starting dialysis using Ozempic ...dont you shrink the population being treated ? We need to see the trial details and also if it would work with SGLT2 inhibitors Kiwi
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.